PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 142 filers reported holding PUMA BIOTECHNOLOGY INC in Q4 2018. The put-call ratio across all filers is 1.87 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $161,000 | -5.3% | 55,900 | +0.2% | 0.00% | – |
| Q4 2021 | $170,000 | -60.7% | 55,800 | -9.6% | 0.00% | – |
| Q3 2021 | $433,000 | -23.5% | 61,700 | 0.0% | 0.00% | – |
| Q2 2021 | $566,000 | -5.7% | 61,700 | 0.0% | 0.00% | – |
| Q1 2021 | $600,000 | -10.0% | 61,700 | -5.1% | 0.00% | – |
| Q4 2020 | $667,000 | +1.7% | 65,000 | 0.0% | 0.00% | – |
| Q3 2020 | $656,000 | -14.9% | 65,000 | -12.0% | 0.00% | – |
| Q2 2020 | $771,000 | +13.5% | 73,900 | -8.2% | 0.00% | – |
| Q1 2020 | $679,000 | -3.6% | 80,500 | 0.0% | 0.00% | – |
| Q4 2019 | $704,000 | -18.8% | 80,500 | 0.0% | 0.00% | -100.0% |
| Q3 2019 | $867,000 | -4.3% | 80,500 | +12.9% | 0.00% | 0.0% |
| Q2 2019 | $906,000 | -48.9% | 71,300 | +56.0% | 0.00% | 0.0% |
| Q1 2019 | $1,773,000 | +90.6% | 45,700 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $930,000 | -88.2% | 45,700 | -73.3% | 0.00% | -80.0% |
| Q3 2018 | $7,856,000 | +208.6% | 171,340 | +298.1% | 0.01% | +150.0% |
| Q2 2018 | $2,546,000 | -44.9% | 43,040 | -36.6% | 0.00% | -33.3% |
| Q1 2018 | $4,621,000 | -23.1% | 67,900 | +11.7% | 0.00% | -25.0% |
| Q4 2017 | $6,007,000 | -23.7% | 60,770 | -7.6% | 0.00% | -33.3% |
| Q3 2017 | $7,878,000 | +119.1% | 65,790 | +59.9% | 0.01% | +100.0% |
| Q2 2017 | $3,596,000 | +147.0% | 41,140 | +5.1% | 0.00% | +200.0% |
| Q1 2017 | $1,456,000 | +21.1% | 39,140 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $1,202,000 | -54.2% | 39,140 | 0.0% | 0.00% | -50.0% |
| Q3 2016 | $2,624,000 | +88.1% | 39,140 | -16.4% | 0.00% | +100.0% |
| Q2 2016 | $1,395,000 | +224.4% | 46,840 | +219.9% | 0.00% | – |
| Q1 2016 | $430,000 | -63.0% | 14,640 | -1.3% | 0.00% | -100.0% |
| Q4 2015 | $1,163,000 | -5.4% | 14,840 | -9.0% | 0.00% | 0.0% |
| Q3 2015 | $1,229,000 | -97.6% | 16,314 | -96.2% | 0.00% | -97.6% |
| Q2 2015 | $50,322,000 | -52.7% | 431,021 | -4.4% | 0.04% | -51.2% |
| Q1 2015 | $106,498,000 | +21.4% | 451,053 | -2.7% | 0.09% | +17.8% |
| Q4 2014 | $87,739,000 | -6.4% | 463,566 | +18.0% | 0.07% | -7.6% |
| Q3 2014 | $93,705,000 | +533.7% | 392,776 | +75.3% | 0.08% | +558.3% |
| Q2 2014 | $14,787,000 | -70.7% | 224,047 | -53.8% | 0.01% | -72.7% |
| Q1 2014 | $50,517,000 | +35.4% | 485,091 | +34.6% | 0.04% | +33.3% |
| Q4 2013 | $37,304,000 | +75.5% | 360,325 | -9.0% | 0.03% | +57.1% |
| Q3 2013 | $21,257,000 | +7.3% | 396,142 | -11.3% | 0.02% | 0.0% |
| Q2 2013 | $19,816,000 | – | 446,612 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVARD MANAGEMENT CO INC | 600,000 | $45,216,000 | 3.56% |
| Avalon Global Asset Management LLC | 32,900 | $2,479,000 | 1.79% |
| CORNERSTONE CAPITAL MANAGEMENT LLC | 495,145 | $37,314,000 | 1.58% |
| BB BIOTECH AG | 521,991 | $39,337,000 | 1.25% |
| WEATHERBIE CAPITAL, LLC | 137,041 | $10,327,000 | 1.20% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $428,527,000 | 1.19% |
| TOBAM | 318,384 | $23,994,000 | 0.94% |
| Orbimed Advisors | 1,195,500 | $90,093,000 | 0.91% |
| Capital International Sarl | 109,405 | $8,245,000 | 0.74% |
| CAPITAL INTERNATIONAL LTD /CA/ | 145,697 | $10,980,000 | 0.73% |